AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial

By In The News
January 16, 2019 in The Headlines

Recommended Posts

In The News

Posted January 16, 2019

- Share

Posted January 16, 2019

IRVINE, Calif., Jan. 16, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  217771
2. Jaydee
  15761
3. Kip Powick
  12028
4. deicer
  11472
5. dagger
  9586
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  267.9k
- Total Posts
  
  553.5k

Sign In

AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support